HOMEVULNERABILITIESCVE-2017-18223
HIGH

CVE-2017-18223

CWE-287Published: March 10, 2018· Updated: Jun 17, 2026

8.1
CVSS v3.1

Official Description

BMC Remedy AR System before 9.1 SP3, when Remedy AR Authentication is enabled, allows attackers to obtain administrative access.

NVD Source

Technical Analysis

CVE-2017-18223 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 8.1.

From a weakness classification perspective (CWE-287): Authentication bypass vulnerabilities allow attackers to access protected resources without valid credentials.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected Vendors & Products

bmc1 product(s)
remedy action request system
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

Quick Facts

CVE IDCVE-2017-18223
CVSS Score8.1 / 10
SeverityHIGH
WeaknessCWE-287
CISA KEVNo
Affected1 vendor(s)
PublishedMar 10, 2018

Related CVEs (CWE-287)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2017-18223 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.